Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer
H Kühnle, H G Meerpohl, W Eiermann, et al.
Seminars in Oncology
|
February 1, 1992
Phase II and III studies with carboplatin in small cell lung cancer
U Gatzemeier, D K Hossfeld, R Neuhauss, et al.
Tumori
|
July 1, 1977
Tumors and dental and ocular abnormalities after treatment of infant rats with adriamycin
A M Casazza, O Bellini, F Formelli, et al.
American Journal of Clinical Oncology
|
October 1, 1988
Etoposide and split-dose cisplatin in small-cell lung cancer
H Wilke, W Achterrath, H J Schmoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1992
Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer
U Gatzemeier, D K Hossfeld, R Neuhauss, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer
U Gatzemeier, M Heckmayr, D K Hossfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1983
Phase I study of carboplatin given on a five-day intravenous schedule
M Rozencweig, C Nicaise, M Beer, et al.
Bulletin Du Cancer
|
March 1, 1994
[Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes]
M Chazard, B Pellae-Cosset, F Garet, et al.
Oncology
|
January 1, 1992
Carboplatin/etoposide/vincristine therapy in small cell lung cancer
U Gatzemeier, J von Pawel, R Laumen, et al.
Cancer Chemotherapy Reports
|
September 1, 1973
Cytotoxic, antiviral, and antitumor activity of some derivatives of daunomycin (NSC-82151)
A Di Marco, A M Casazza, T Dasdia, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer
H Kühnle, H G Meerpohl, W Eiermann, et al.
Seminars in Oncology
|
February 1, 1992
Phase II and III studies with carboplatin in small cell lung cancer
U Gatzemeier, D K Hossfeld, R Neuhauss, et al.
Tumori
|
July 1, 1977
Tumors and dental and ocular abnormalities after treatment of infant rats with adriamycin
A M Casazza, O Bellini, F Formelli, et al.
American Journal of Clinical Oncology
|
October 1, 1988
Etoposide and split-dose cisplatin in small-cell lung cancer
H Wilke, W Achterrath, H J Schmoll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1992
Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer
U Gatzemeier, D K Hossfeld, R Neuhauss, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer
U Gatzemeier, M Heckmayr, D K Hossfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1983
Phase I study of carboplatin given on a five-day intravenous schedule
M Rozencweig, C Nicaise, M Beer, et al.
Bulletin Du Cancer
|
March 1, 1994
[Taxol (paclitaxel), first molecule of a new class of cytotoxic agents: taxanes]
M Chazard, B Pellae-Cosset, F Garet, et al.
Oncology
|
January 1, 1992
Carboplatin/etoposide/vincristine therapy in small cell lung cancer
U Gatzemeier, J von Pawel, R Laumen, et al.
Cancer Chemotherapy Reports
|
September 1, 1973
Cytotoxic, antiviral, and antitumor activity of some derivatives of daunomycin (NSC-82151)
A Di Marco, A M Casazza, T Dasdia, et al.
Page
of 5